Literature DB >> 14747065

Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours.

A Etges1, F D Nunes, K C B Ribeiro, V C Araújo.   

Abstract

The expression of G1-phase cell-cycle regulators is commonly deregulated in human malignancies. In the present study, we investigate components of the retinoblastoma (RB) pathway in normal salivary glands (NSG) and in salivary gland tumours (SGT). Samples of NSG, pleomorphic adenoma (PA), adenoid cystic carcinoma (ACC), mucoepidermoid carcinoma (MEC), epithelial-myoepithelial carcinoma (EMC), malignant myoepithelioma (MEM), carcinoma ex pleomorphic adenoma (CEPA), and polymorphous, low-grade adenocarcinoma (PLGA) were examined immunohistochemically using antibodies to cyclin D1, cyclin-dependent kinase 4 (CDK-4), retinoblastoma protein (pRb), CDK inhibitor p16 and transcription factor E2F-1. In normal salivary glands, cyclin D1 and cdk-4 were not expressed in any case while p16 was positively expressed. pRb was abundant and E2F-1 moderately expressed. In tumors, cdk-4 was overexpressed in half of the cases. Most tumour cases showed decreased pRb immunoexpression compared to normal salivary glands. In contrast, expression of p16 and E2F-1 increased. pRb expression was absent in three cases of PA, two of EMC and one of CEPA. One case of MEM and one of PLGA showed no E2F-1 expression. Statistical analyses revealed positive correlations between cyclin D1 and cdk-4, cyclin D1 and E2F-1, cdk-4 and E2F-1, and p16 and E2F-1. The benign and malignant tumours expressed retinoblastoma pathway proteins differently form the normal salivary gland. Our findings suggest that, pRb pathway deregulation in salivary gland neoplasms is unrelated to their biological behaviour.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747065     DOI: 10.1016/j.oraloncology.2003.08.021

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  HPV infection and p16 expression in carcinomas of the minor salivary glands.

Authors:  Markus Brunner; Oskar Koperek; Fritz Wrba; Boban M Erovic; Gregor Heiduschka; Christian Schoppper; Dietmar Thurnher
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-30       Impact factor: 2.503

2.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

3.  Clinicopathological characteristics and cell cycle proteins as potential prognostic factors in myoepithelial carcinoma of salivary glands.

Authors:  F Passador-Santos; M Grönroos; J Irish; R Gilbert; P Gullane; B Perez-Ordonez; A Mäkitie; I Leivo
Journal:  Virchows Arch       Date:  2015-12-28       Impact factor: 4.064

4.  Overexpression of the pituitary tumor transforming gene upregulates metastasis in malignant neoplasms of the human salivary glands.

Authors:  Jia Liu; Yuguang Wang; Hong He; Wulong Jin; Rong Zheng
Journal:  Exp Ther Med       Date:  2015-06-10       Impact factor: 2.447

5.  Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

Authors:  Yan Zhao; Jing Tan; Li Zhuang; Xia Jiang; Edison T Liu; Qiang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

6.  Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases.

Authors:  G Jour; K West; V Ghali; D Shank; G Ephrem; B M Wenig
Journal:  Head Neck Pathol       Date:  2013-01-13

7.  Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report.

Authors:  Gabriella Aquino; Renato Franco; Fioravante Ronconi; Annamaria Anniciello; Luigi Russo; Annarosaria De Chiara; Luigi Panico
Journal:  Diagn Pathol       Date:  2012-07-06       Impact factor: 2.644

8.  Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors.

Authors:  Harish Kumar; R Vandana; Gs Kumar
Journal:  J Oral Maxillofac Pathol       Date:  2011-09

9.  Expression of cyclin-dependent kinase inhibitor 2A 16, tumour protein 53 and epidermal growth factor receptor in salivary gland carcinomas is not associated with oncogenic virus infection.

Authors:  Ellen Senft; Juliana Lemound; Angelika Stucki-Koch; Nils-Claudius Gellrich; Hans Kreipe; Kais Hussein
Journal:  Int J Oral Sci       Date:  2015-03-23       Impact factor: 6.344

10.  Genomic landscape of salivary gland tumors.

Authors:  Shumei Kato; Sheryl K Elkin; Maria Schwaederle; Brett N Tomson; Teresa Helsten; Jennifer L Carter; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.